个人简介
周涛
职务: 主任医师
专业: 内科肿瘤学
Education/Professional Experience
2000 - 2003 M.S. of Clinical Oncology, Dalian Medical University
1986 - 1991 Bachelor of Medicine (Equivalent to M.D.), Chinese Medical University
2005. 09 - 2005.12 Department of integrated traditional and western medical oncology, China-Japan Friendship Hospital
2000.04-2000.06 Department ofHematological tumor, Harbin blood tumor research Institute
2016.10-2016-12 UAB Comprehensive Cancer Center, USA
1991- Department ofMedical Oncology, the First Affiliated Hospital of Dalian Medical University
Research Projects/Grants
1.2014-2016 Chemotherapy sensitive genes and prognosis in patients with postoperative lung adenocarcinoma. Project of Wu Jieping Foundation
2.2010-2013 Biomolecular analysis of Adjuvant targeted therapy in patients with postoperative NSCLC. Dalian Bureau of science and technology fund
3.2009-2012 EGFR mutation status and small molecular targeted therapy in patients with lung adenocarcinoma. Liaoning Bureau of science and technology fund
Admission Plan/Requirements
2 persons/ smart and dedicated to medical oncology
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Zhou T, Zhang X, Dong Y, Zhuang F et,al. High-dose OxyContin to treat pain associated with bone metastasis in patients with small-cell lung cancer: a case study report.Drug Des Devel Ther. 2016 Jan 19;10:383-7. doi: 10.2147
2.Liu Suqin, Wang Hongjiang, Zhang Lizhi et al.Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing. Hum Genomics. 2015, 9(1): 2-12. (Correspondence author)
3.Zhou Tao, Lv Ping, Liu Suqin et al. Effectiveness of gefitinib and relationship of EGFR mutation and VEGF expression in patients with lung adenocarcinoma. J Clinical Pulmonary Diseases. 2012, 17(12): 2233-2234.
4.Zhang Jing, Liu Suqin, Zhang Jie et al.Effectiveness and cost benefit analysis of different regimenin patients with advanced NSCLC. Journal of Chinese Clinical Oncology, 2012, 17(10): 908-911. (Correspondence author)
5.Zhang Lei, Liu Suqin，WangQuandong et al.Relationship of platin-based chemotherapy and peripheral blood Expression of ERCC1 in patients with advanced NSCLC. Journal of Clinical meta-analysis，2012, 27(18) 1575-1579. (Correspondence author)
学术兼职
Member of Chinese Society of Clinical Oncology (CSCO)
Member of the standing committee of the world associationChinese oncologist
Member of China Research and Promotion of Traditional Chinese Medicine
Member of the standing committee of Professional committee of palliative care research of world federation ofChinese medicine society
Member of the standing committee of Chinese medicine education association of professional committee of lung cancer
Member of Institute of chemotherapy, Liaoning Province Anti-cancer Association
京公网安备 11010802027423号